Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127705031 | 12770503 | 1 | I | 20160902 | 20160915 | 20160922 | 20160922 | EXP | PT-INFARMED-N201609-20 | PHHY2016PT127379 | NOVARTIS | 41.00 | YR | F | Y | 0.00000 | 20160922 | OT | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127705031 | 12770503 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 20234 | EXTENDED RELEASE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127705031 | 12770503 | 1 | Migraine prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127705031 | 12770503 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127705031 | 12770503 | Dyspnoea | |
| 127705031 | 12770503 | Erythema | |
| 127705031 | 12770503 | Generalised erythema | |
| 127705031 | 12770503 | Pruritus | |
| 127705031 | 12770503 | Pruritus generalised | |
| 127705031 | 12770503 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127705031 | 12770503 | 1 | 20160805 | 20160903 | 0 |